Spots Global Cancer Trial Database for Blood Test to Measure DNA Damage in Blood
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Blood Test to Measure DNA Damage in Blood
Official Title: Gamma-H2AX as a Molecular Predictor of Prostate Cancer Radiosensitivity
Study ID: NCT00523471
Conditions
Interventions
Study Description
Brief Summary: To check the radiosensitivity level in individual patients based on their DNA damage level.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Cross Cancer Institute, Edmonton, Alberta, Canada
Contact Details
Name: Nadeem Pervez, MBBS, FRCPC
Affiliation: AHS Cancer Control Alberta
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
